20250171469. Modulators (Vertex Pharmaceuticals Incorporated)
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Abstract: this disclosure provides modulators of cystic fibrosis transmembrane conductance regulator (cftr), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.
Inventor(s): Alexander Russell ABELA, Jeremy J. CLEMENS, Peter Diederik Jan GROOTENHUIS, Sara Sabina HADIDA RUAH, Yoshihiro ISHIHARA, Haripada KHATUYA, Jason McCARTNEY, Mark Thomas MILLER, Fabrice Jean Denis PIERRE, Joe Anh TRAN, Jinglan ZHOU
CPC Classification: C07F7/0816 (ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins ))
Search for rejections for patent application number 20250171469
- Patent Applications
- Vertex Pharmaceuticals Incorporated
- CPC C07F7/0816
- Alexander Russell ABELA of Escondido CA US
- Jeremy J. CLEMENS of San Diego CA US
- Peter Diederik Jan GROOTENHUIS of Del Mar CA US
- Sara Sabina HADIDA RUAH of La Jolla CA US
- Yoshihiro ISHIHARA of San Diego CA US
- Haripada KHATUYA of San Diego CA US
- Jason McCARTNEY of Cardiff by the Sea CA US
- Mark Thomas MILLER of Rancho Santa Fe CA US
- Fabrice Jean Denis PIERRE of La Jolla CA US
- Joe Anh TRAN of San Marcos CA US
- Jinglan ZHOU of San Diego CA US